Sinusoidal endothelial cells control liver inflammation and fibrosis
Open Access
- 9 April 2026
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (11)
Abstract
Liver fibrosis is a common pathological outcome of chronic liver disease and is driven by inflammatory responses. However, the early signals that initiate the inflammatory cascade remain poorly understood. Emerging evidence suggests that liver sinusoidal endothelial cells (LSECs) are not merely passive bystanders, but active regulators during liver fibrosis. In this issue of the JCI , Gan et al. demonstrated in multiple preclinical models that BRD4/PML-mediated super-enhancer activation in LSECs drives proinflammatory angiocrine signaling, thereby initiating liver fibrosis. Thus, targeting this endothelial axis may offer a promising therapeutic strategy for the treatment of liver fibrosis.Keywords
This publication has 25 references indexed in Scilit:
- Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiersTrends in Pharmacological Sciences, 2025
- The role of liver sinusoidal endothelial cells in liver diseases: Key players in health and pathologyJournal of Hepatology, 2025
- Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cellsCellular & Molecular Immunology, 2025
- Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolutionNature Communications, 2025
- Angiocrine signaling in sinusoidal homeostasis and liver diseasesJournal of Hepatology, 2024
- Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesisJournal of Hepatology, 2024
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivoJournal of Hepatology, 2022
- Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine SignalingHepatology, 2021
- Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signalingJournal of Hepatology, 2021